Boston Scientific Corp (BSX) Stock Analysis

Boston Scientific Corp (BSX) is a publicly traded company in the HEALTHCARE sector. It trades at $44.76, carries a market capitalization of $66.87B, a price-to-earnings ratio of 18.75. This page summarizes the public market data, fundamentals, and frequently asked questions for BSX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

Price: $44.76
Market Cap: $66.87B
P/E Ratio: 18.75
EPS: $2.40
52-Week High: $109.50
52-Week Low: $42.25

Market Sentiment

Boston Scientific Corp currently has a Neutral sentiment score of 0.15.

About Boston Scientific Corp

Boston Scientific Corporation (BSX) is a leading global medical device manufacturer that specializes in providing innovative solutions across key medical specialties, including cardiology, neuromodulation, and oncology. With a strong emphasis on research and development, the company is dedicated to enhancing patient outcomes through cutting-edge technology and strategic collaborations. Boston Scientific's extensive portfolio and commitment to advancing healthcare innovation position it to eff...

GNG Research Analysis

GNG Research scores Boston Scientific Corp (BSX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BSX.

Frequently Asked Questions

Does BSX pay dividends?

Boston Scientific Corp (BSX) does not currently pay a regular dividend.

What is BSX's P/E ratio?

Boston Scientific Corp has a price-to-earnings (P/E) ratio of 18.75.

What is BSX's market cap?

Boston Scientific Corp (BSX) has a market capitalization of $66.87B with a current stock price of $44.76.